SEC Form 4 · accession 0001209191-16-136929
XBiotech Inc. · XBIT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Trey Benson
Officer — VP of Commercial Development
Period of report
Aug 12, 2016
Accepted (ET)
Aug 15, 2016 · 12:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001626878
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock options | $0.00 | Jun 20, 2016 | A | 8,000 | A | Dec 6, 2016 | Jun 5, 2026 | Common Stock | 8,000 | 8,000 | D |
Remarks
Trey Benson joined the company on June 20, 2016. On August 12, 2016, the board approved to add Trey Benson as Section 16 officer